Advertisement
Screener

INMUNE BIO INC. (INMB) Net Margin

INMUNE BIO INC. (INMB) Net Margin

  • 2025-03-31: Net Margin -19478.00%.
  • 2024-03-31: Net Margin -78750.00%.
  • 2023-12-31: Net Margin -30028.57%.
  • 2023-09-30: Net Margin -19913.95%.

Complete source-backed net margin history.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Net Margin

DateNet Margin
2025-03-31-19478.00%
2024-03-31-78750.00%
2023-12-31-30028.57%
2023-09-30-19913.95%
2023-06-30-14132.61%
2023-03-31-17200.00%
2022-12-31-6013.40%
2022-09-30-7882.65%
2022-06-30-42737.50%
2022-03-31-4234.97%
2021-12-31-5933.13%
2021-09-30-67557.14%
2021-03-31-113900.00%

Annual Net Margin

DateNet Margin
2025-12-31-91866.00%
2024-12-31-300585.71%
2023-12-31-19360.00%
2022-12-31-7299.20%
2021-12-31-16762.43%
2020-12-31-109990.91%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B